Conferences
GU Cancers Symposium 2014 - Long-term quality of life in high-risk prostate cancer: Results of a phase III randomized trial - Abstract
January 30, 2014
Dendreon announces presentation of PROVENGE® (sipuleucel-T) data at the 2014 Genitourinary Cancer Symposium (ASCO GU)
January 30, 2014
GU Cancers Symposium 2014 - Newest-generation androgen therapies with radiation or surgery - Session Highlights
January 30, 2014
GU Cancers Symposium 2014 - Beyond enzalutamide and abiraterone: What’s next in androgen therapy? - Session Highlights
January 30, 2014
GU Cancers Symposium 2014 - Dissecting the biology of the androgen receptor pathway - Session Highlights
January 30, 2014
Myriad's Prolaris® test significantly modifies treatment decisions for patients with prostate cancer
January 29, 2014
Symposium highlights latest research advances in GU cancers
January 28, 2014
GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Slide Presentation
January 28, 2014